etiron has been researched along with Shock in 1 studies
etiron: a nitric oxide synthase inhibitor; RN given refers to parent cpd; structure
Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "2." | 1.29 | Effects of S-ethylisothiourea, a potent inhibitor of nitric oxide synthase, alone or in combination with a nitric oxide donor in splanchnic artery occlusion shock. ( Altavilla, D; Campo, GM; Canale, P; Caputi, AP; Ioculano, M; Rossi, F; Saitta, A; Squadrito, F; Squadrito, G, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Squadrito, F | 1 |
| Altavilla, D | 1 |
| Squadrito, G | 1 |
| Campo, GM | 1 |
| Ioculano, M | 1 |
| Canale, P | 1 |
| Rossi, F | 1 |
| Saitta, A | 1 |
| Caputi, AP | 1 |
1 other study available for etiron and Shock
| Article | Year |
|---|---|
Effects of S-ethylisothiourea, a potent inhibitor of nitric oxide synthase, alone or in combination with a nitric oxide donor in splanchnic artery occlusion shock.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Blood Pressure; Drug Therapy, Combination; In Vitro Techniq | 1996 |